Levin Capital Strategies, L.P. Johnson & Johnson Transaction History

Levin Capital Strategies, L.P.

$952 Million
Q2 2024

A detailed history of Levin Capital Strategies, L.P. transactions in Johnson & Johnson stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 212,042 shares of JNJ stock, worth $34.9 Million. This represents 3.26% of its overall portfolio holdings.

Number of Shares

212,042

Previous 213,083 0.49%

Holding current value

$34.9 Million

Previous $33.7 Million 8.05%

% of portfolio

3.26%

Previous 3.39%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$144.38 - $157.78 $150,299 - $164,248	-1,041 Reduced 0.49%	212,042 $31 Million
Q1 2024 May 16, 2024	BUY	$155.22 - $162.74 $9,778 - $10,252	63 Added 0.03%	213,083 $33.7 Million
Q4 2023 Feb 06, 2024	SELL	$145.6 - $158.88 $218,108 - $238,002	-1,498 Reduced 0.7%	213,020 $33.4 Million
Q3 2023 Oct 31, 2023	SELL	$155.75 - $174.48 $876,872 - $982,322	-5,630 Reduced 2.56%	214,518 $33.4 Million
Q2 2023 Jul 31, 2023	SELL	$154.35 - $166.11 $473,082 - $509,127	-3,065 Reduced 1.37%	220,148 $36.4 Million
Q1 2023 Apr 24, 2023	SELL	$151.05 - $180.26 $220,533 - $263,179	-1,460 Reduced 0.65%	223,213 $34.6 Million
Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $23,869 - $26,788	-149 Reduced 0.07%	224,673 $39.7 Million
Q3 2022 Nov 08, 2022	SELL	$161.33 - $179.52 $1.18 Million - $1.31 Million	-7,314 Reduced 3.15%	224,822 $36.7 Million
Q2 2022 Aug 15, 2022	SELL	$168.19 - $186.01 $1.21 Million - $1.34 Million	-7,219 Reduced 3.02%	232,136 $41.2 Million
Q1 2022 May 02, 2022	SELL	$158.14 - $179.59 $373,052 - $423,652	-2,359 Reduced 0.98%	239,355 $42.4 Million
Q4 2021 Feb 15, 2022	SELL	$155.93 - $173.01 $365,188 - $405,189	-2,342 Reduced 0.96%	241,714 $41.4 Million
Q3 2021 Nov 10, 2021	SELL	$161.5 - $179.47 $36,337 - $40,380	-225 Reduced 0.09%	244,056 $39.4 Million
Q2 2021 Aug 11, 2021	SELL	$159.48 - $171.07 $131,571 - $141,132	-825 Reduced 0.34%	244,281 $40.2 Million
Q1 2021 May 05, 2021	SELL	$153.07 - $170.48 $828,108 - $922,296	-5,410 Reduced 2.16%	245,106 $40.3 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $453,148 - $520,140	-3,305 Reduced 1.3%	250,516 $39.4 Million
Q3 2020 Nov 17, 2020	BUY	$140.38 - $153.83 $385,623 - $422,571	2,747 Added 1.09%	253,821 $37.8 Million
Q2 2020 Aug 13, 2020	SELL	$128.81 - $155.51 $2.58 Million - $3.11 Million	-20,027 Reduced 7.39%	251,074 $35.3 Million
Q1 2020 May 13, 2020	SELL	$111.14 - $153.99 $361,205 - $500,467	-3,250 Reduced 1.18%	271,101 $35.5 Million
Q4 2019 Feb 10, 2020	BUY	$127.5 - $146.44 $342,210 - $393,044	2,684 Added 0.99%	274,351 $40 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $47,606 - $53,302	-375 Reduced 0.14%	271,667 $35.1 Million
Q2 2019 Aug 13, 2019	BUY	$131.15 - $144.24 $1.73 Million - $1.9 Million	13,205 Added 5.1%	272,042 $37.9 Million
Q1 2019 May 13, 2019	SELL	$125.72 - $139.79 $139,800 - $155,446	-1,112 Reduced 0.43%	258,837 $36.2 Million
Q4 2018 Feb 05, 2019	SELL	$122.84 - $147.84 $10.3 Million - $12.5 Million	-84,226 Reduced 24.47%	259,949 $33.5 Million
Q3 2018 Oct 29, 2018	SELL	$121.58 - $142.88 $20,668 - $24,289	-170 Reduced 0.05%	344,175 $47.6 Million
Q2 2018 Aug 07, 2018	SELL	$119.4 - $131.76 $9.8 Million - $10.8 Million	-82,042 Reduced 19.24%	344,345 $41.8 Million
Q1 2018 May 18, 2018	SELL	$125.1 - $148.14 $1.13 Million - $1.34 Million	-9,028 Reduced 2.07%	426,387 $54.6 Million
Q4 2017 Feb 09, 2018	SELL	$131.22 - $143.62 $239,476 - $262,106	-1,825 Reduced 0.42%	435,415 $60.8 Million
Q3 2017 Nov 13, 2017	BUY	$129.47 - $135.38 $56.6 Million - $59.2 Million	437,240	437,240 $56.8 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $431B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Levin Capital Strategies, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Levin Capital Strategies, L.P. with notifications on news.

Account

Levin Capital Strategies, L.P. Johnson & Johnson Transaction History